Dogs used in scientific research would need to be considered for adoption before they can be routinely euthanized under legislation passed this week in New York.
The measure — focused on beagles because they are most commonly bred for research use — has been sent to Gov. Andrew Cuomo to be signed into law, WGRZ reports.
The Research Animal Retirement Act — also referred to as the “Beagle Freedom Bill” — would require all educational institutions that use dogs or cats in research to establish adoption programs.
The law would mandate that a veterinarian determine whether a beagle or other animal that is no longer useful to researchers is medically suitable for adoption. If approved for adoption, the animal would then be shipped to a shelter or given to an interested owner.
Similar laws have been passed in Nevada, California, Minnesota, and Connecticut.
“This bill, once it is signed into law, will mean that research animals will have a chance at a second life,” said one sponsor of the legislation, Assemblywoman Linda Rosenthal, D-Manhattan.
“All animals, being freed of their testing responsibilities, should be afforded the opportunity of a loving, forever home to live the remainder of their days,” said another, Sen. Phil Boyle, R-Suffolk County.
The The Beagle Freedom Project — whose work is featured in the video above — has mounted campaigns in several more states to get the law passed.
The New York law requires publicly-funded higher education research facilities to take reasonable steps to provide for the adoption of dogs and cats when they are no longer being used for scientific research.
While federal laws regulate animal research, they do not protect dogs and cats from being euthanized when their services are no longer needed.
Some research facilities, however, have instituted their own adoption programs.
“These dogs and cats deserve to live normal lives as companion animals once their time in the laboratory ends,” said Brian Shapiro, New York state director for The Humane Society of the United States.
“People who have adopted former research dogs and cats can attest to the resilience and affection of these animals once they are given the chance to flourish in a home environment,” he said.
Posted by John Woestendiek June 16th, 2016 under Muttsblog, videos.
Tags: adoption, animals, beagle freedom bill, beagle freedom project, beagles, dog, dogs, euthanasia, euthanized, freedom, homes, lab, laboratory, law, legislation, new york, pets, protection, research, research animal retirement act
The largest of the country’s three remaining Class B dog dealers — those often unscrupulous sorts who scrounge up dogs and sell them to laboratories for use in experiments — is going out of business.
The Humane Society of the United States reported yesterday that Ohio-based dealer Robert Perry has cancelled his license with the U.S. Department of Agriculture.
That means only two licensed “random source” dealers remain. Class B, or random source, dealers round up dogs from flea markets, shelters, auctions, Craigslist and other sources and sell them to research institutions.
“These merchants of cruelty are on their last gasps, and this announcement gets us one big step closer to the complete demise of this sordid trade,” Wayne Pacelle, president and CEO of The Humane Society of the United States, writes on the HSUS blog, A Humane Nation.
Perry has been supplying dogs for years to a number of institutions, including Ohio State University. Between October 2013 and October 2014, OSU purchased nearly 50 dogs from Perry, making him the biggest random source supplier of dogs used in research nationwide.
Of the two remaining Class B dealers, one had only four dogs in its most recent inventory and the other is facing formal enforcement action from the USDA, according to HSUS.
At one time there were more than 200 licensed Class B dealers in the United States. By 2013, as a result of a decline in the use of dogs in laboratories and opposition from groups like HSUS, Last Chance for Animals, the Doris Day Animal League, and the Animal Welfare Institute, that number was down to six
Last year’s announcement from the National Institutes of Health that it would no longer fund research that used random source dogs served as a final nail in the coffin for Class B dog dealing.
The NIH decision stemmed from a report issued by the National Academy of Sciences that found random source dealers could not guarantee that people’s pets would not end up in laboratories.
Those dogs who are bred for laboratory research — commonly beagles — weren’t directly affected by that decision, but, as Pacelle notes, they are being used less often by laboratories, too.
“The continuing and rapid decline of these random source Class B dealers means the chances of pets ending up in laboratories are now very low,” Pacelle said.” And we’re perhaps closer to the day when fewer dogs of any kind are used in testing and research.”
(Photo: A “random source” dog that was used in dental experiments at Georgia Regents University that were the subject of an HSUS investigation; courtesy of HSUS)
Posted by John Woestendiek May 7th, 2015 under Muttsblog.
Tags: animal welfare, animals, class b, dealers, department of agriculture, dog, dog dealers, dogs, experiments, hsus, humane society of the united states, laboratory, license, pets, random source, research, supply, usda, wayne pacelle
A physician’s organization led a rally this week urging Wayne State University to end its long-running series of cardiac research experiments on dogs.
About 45 people joined in the protest, led by the Physicians Committee for Responsible Medicine.
According to the nonprofit organization, the heart failure experiments have been going on for 20 years, at a cost to taxpayers of about $8 million, and have provided no information beneficial to treating human heart disease.
No dogs leave the program alive.
“These research experiments have not garnered anything that has advanced human health,” said Jennifer Giordano, a Detroit-area doctor representing the committee. “We want them to use human-relevant research methods.”
In the experiments, heart problems are induced in the dogs by the use of implanted electrodes, which cause their heart rates to more than double.
The dogs are then put through multiple surgeries and are required to run on treadmills. About 25 percent of the dogs die during or after the surgery. Those who do survive are euthanized when their participation is no longer needed.
The experiments are funded in part by the National Institutes of Health.
At the Wednesday rally the Physicians Committee for Responsible Medicine presented a letter signed by actress Lily Tomlin to Wayne State University officials, calling on them to end medical experiments on dogs. Tomlin is a Detroit native and attended the university.
In the letter, Tomlin wrote: “I understand that Wayne State is spending millions of taxpayer dollars using dogs in heart failure experiments that have not benefited human health in any way. I urge you to end these senseless experiments as soon as possible.”
A copy of the letter was given to Matt Lockwood, a university spokesman who came to the rally and a read a statement defending the experiments, the Detroit News reported.
“Almost every medical advance in the last 100 years was due to research on animals — chemotherapy, hip replacements, transfusions, dialysis — was all tested on dogs,” Lockwood said. “We need to continue to do research to advance science.”
He said the animals in the experiments are under the constant supervision of veterinarians.
“There’s a committee that’s sole purpose is to ensure the animals are as comfortable as possible,” he said. “We’re also under the oversight of the federal government and the state. Never once has any animal been found to have been mistreated at any time.”
He said the dogs are euthanized after taking part in the experiments, but he declined to provide numbers.
(Photo: Daniel Mears / Detroit News)
Posted by John Woestendiek April 10th, 2015 under Muttsblog.
Tags: animals, cardiac, cease, detroit, disease, dog, dogs, end, experimentation, experiments, failure, heart, induced, laboratory, letter, lily tomlin, medical, pets, physicians committee for responsible medicine, protest, rally, research, science, stop, surgery, wayne state university
Two University of Washington scientists think it might be possible to slow the aging process in canines and are launching a pilot study with 30 dogs to see if the drug rapamycin significantly extends their lifespans.
The researchers, using $200,000 in seed money from the University of Washington, plan to use pets, not laboratory animals, for the initial study, and recruit volunteer dogs — or at least dogs whose owners volunteer them — for larger scale studies in the future.
Daniel Promislow, an evolutionary geneticist, and Matthew Kaeberlein, a molecular biologist, say the study is aimed at determining whether rapamycin could lead to longer lives for dogs — as studies have shown is the case when it’s used on yeast, fruit flies, worms and mice.
“We’re not talking about doubling the healthy life spans of pets,” said Kaeberlein. “But at a minimum I would predict that you would get a 10 to 15 percent increase in average life span, and I think bigger effects are possible.”
In the pilot study, 30 large, middle-aged dogs will be involved — half receiving low doses of rapamycin, half receiving placebos.
The researchers say that subsequent studies will seek to enroll pet dogs from across the country.
Kaeberlein and Promislow hosted a meeting in Seattle last week where experts from across the country discussed the drug rapamycin and its possible effects on the health and longevity of dogs, the Seattle Times reported.
Currently used along with other medications to prevent rejection in organ-transplant patients, rapamycin has been called a promising anti-aging drug — though there have been no studies involving humans.
But almost 50 laboratory studies have shown that the compound can delay the onset of some diseases and degenerative processes and restore vigor to elderly animals, extending life spans by 9 to 40 percent.
Rapamycin functions, in part, by inactivating a protein that promotes cell growth. As a result, cells grow more slowly, which retards the spread of cancer.
Promislow, who has two elderly dogs of his own, noted that even if the drug doesn’t increase the life span of dogs, it could serve to keep them healthy longer. “We’re trying to understand why some dogs age better than others, and help all dogs age in a better way,” he said.
The drug has been shown to have serious side effects, including poor wound healing and an increased risk of diabetes, when used at the high doses required for organ transplant patients.
But the low doses used in anti-aging research with mice and other lab animals cause few side effects.
There have been no large-scale human trials. Studying how the drug affects dogs — who suffer many of the same old-age ailments as their masters — makes it possible to explore the possible benefits of rapamycin both more quickly and at a lesser cost.
If it does turn out to be a sort of fountain of youth — for dogs, humans, or both — the potential profits would be enormous.
“I think it’s worth a go, not just from what it can teach us about humans, but for the sake of the animals themselves,” said University of Alabama Biology Department Chairman Steven Austad, an expert in aging research who is not involved in the project. “It may not work in dogs, but if it did, boy, it’s going to be huge.”
According to the Seattle Times article, drug companies aren’t very interested in rapamycin because it’s no longer under patent.
But the researchers are hoping dog lovers, dog-food companies and some foundations might be willing to contribute to further research.
They’ve set up a website, dogagingproject.com,where people can donate and sign their dogs up to take part in the research.
“Given how I feel about my pets, I see this as a unique project where there’s a real potential for citizen science,” Kaeberlein said. “I think it would be great if pet owners who are really interested in improving the health of their animals would help fund this work.”
(Photos: UW scientists Matt Kaeberlein, with his dog Dobby, and Dan Promislow, with his dog Frisbee; by Steve Ringman / The Seattle Times)
Posted by John Woestendiek November 4th, 2014 under Muttsblog.
Tags: animals, anti aging, anti aging drug, biology, cancer, cells, citizen science, compound, Daniel Promislow, death, dog, dogs, drug, drugs, extending, fountain of youth, funding, geneticist, health, ifespan, laboratory, life, lifespans, lives, longer, Matthew Kaeberlein, molecular, pets, rapamycin, research, sickness, study, university of washington
A golden retriever named Bretagne is all over the Internet today — today being 9/11 — looking much grayer around the muzzle than she did in 2001 and being described as the only search and rescue dog at the World Trade Center who is still living.
Whether that’s accurate depends on how you define “living.”
Not to pick nits, but there’s another dog, a German shepherd named Trakr — said by some to have found the last human survivor of the World Trade Center attack — who lives on … in a way.
Trakr was cloned in 2009, after his owner, a police officer turned actor, won an essay contest seeking the world’s most “cloneworthy” dog.
It’s a long story, one you can read about in the book, “DOG, INC.,” which recounts how dog cloning became a commercial enterprise.
Here’s the short version: Trakr was the partner of James Symington, a Halifax, Nova Scotia, police officer. When Trakr was retired, Symington claimed him as his own. On Sept. 11, 2001, after seeing news reports, Symington, without authorization from his department, took Trakr to the World Trade Center.
There, as Symington recounts it, Trakr discovered Genelle Guzman buried in the rubble — the last survivor found.
Others dispute his account.
Symington later moved to California to pursue a career in acting, taking Trakr with him. When an American company called BioArts announced it was holding a “Golden Clone Giveaway,” Symington submitted an essay, and won.
BioArts footed the bill (about $150,000) and sent samples of Trakr’s DNA to South Korean veterinarian Hwang Woo-Suk, who was on the team at Seoul National University that produced the world’s first canine clone, Snuppy. He’d since been fired and opened his own laboratory, Sooam Biotech Research Foundation.
Trakr’s DNA was inserted into five “surrogate” egg cells, each of which was zapped with electricity and implanted into a different female dog.
In June 2009 five clone puppies were born and, a few months later, delivered to Symington. He named them Trustt, Solace, Valor, Prodigy, and Deja Vu, and said he planned to train them all as search as rescue dogs who would carry on Trakr’s legacy.
They seem to have fallen out of the limelight since then, and their Facebook page hasn’t been updated for a couple of years.
Earlier this year, the man who pushed dog cloning and sponsored the “Golden Clone Giveaway,” in an apparent turnaround, said cloning dogs — a service still offered in South Korea — was not a viable, profitable, or humane pursuit, noting that it took up to 80 dogs to clone just one.
Lou Hawthorne headed BioArts, and spearheaded the earliest (unsuccessful) efforts to clone dog at Texas A&M University. That research was funded by University of Phoenix founder John Sperling, who died last month.
While some of the main characters involved in dog cloning seem to be fading from public view, from Trakr’s clones to Sperling, dog cloning is not — Sooam Biotech is still carrying out clonings for customers who want duplicates of their dead or dying pets, at a price that has dropped to about $100,000.
But back to the dog who is in the news — Bretagne. She returned this week to the site of the former World Trade Center complex with her longtime handler and owner, where they were interviewed by Tom Brokaw for NBC’s Today Show.
Bretagne (pronounced “Brittany”) is one of eight finalists for the American Humane Association’s annual Hero Dog Awards, and later this month she’ll travel with her owner to Beverly Hills for the awards ceremony.
My hunch, and hope, is that Bretagne is not destined to be cloned, and that her owner realizes what many customers of dog cloning have not — every dog, and every person, is one of a kind. And one of a kind means one of a kind. That special something inside your dog can’t be re-created in a laboratory.
Posted by John Woestendiek September 11th, 2014 under Muttsblog.
Tags: 9-11, 911, animals, bioarts, bretagne, cloned, clones, cloning, death, dog, dog cloning, dog inc., dogs, golden clone giveaway, james symington, laboratory, last, life, living, pets, re-creating, rescue, search, search and rescue, September 11, sooam, surviving, trakr, world trade center
You’d think Brian Andrews, as an investigative reporter at CBS News in Miami, would have plenty of legitimate and important issues to pursue — given all the land-raping, government corruption, injustice, drugs and sleaze the state of Florida has to offer.
Instead, he took his investigative skills inside a dog’s mouth. And he discovered there were germs in there.
News flash? Not exactly. We present it here not because it’s breaking news, but because it’s a good example of broken news — the kind of dopey reports that are increasingly common these days as TV news outfits, like newspapers, and websites, opt for quick and easy, crowd-scaring or crowd-pleasing, stories, then do their best to hype, tease and sensationalize them.
To determine whether you should let your dog lick your face, Andrews, a member of the station’s “special projects” team, gathered saliva samples from dogs in Fort Lauderdale and West Palm Beach and sent them to a lab to be tested, as part of the station’s continuing series called “How Dirty Is It?”
He was trying to determine if the adage nobody believes in the first place — the one about a dog’s mouth being a pristinely clean place — was really true.
We all know, or should, that there are going to be germs in a dog’s mouth, based simply on the sort of things that go in there. We also know, or should, that there are also plenty of germs in our own.
Upon completion of the doggy saliva tests, Nova Southeastern University microbiologist Dr. Julie Torruellas-Garcia concluded, “There was quite a bit of bacteria that grew from the dogs’ mouths.”
Based on the cultures grown in the lab from the samples, she said, there was “evidence of Nyceria, which is linked to STDs, pneumonia and plaque.”
“While our testing did not reveal the presence of any e-coli or bacteria that could cause a staph infection, Dr. Torruellas-Garcia and her students found globs of other microbes,” the news report said.
“You may want to think twice,” the report reads, “before you and your dog exchange siliva.” (We’re pretty sure they meant saliva.)
After raising fears about mouth to mouth contact with dogs, Andrews, in a complete turnaround, goes on to present a veterinarian who said kissing your dog isn’t all that dangerous. West Palm Beach Veterinarian Ken Simmons said any bacteria in a dog’s mouth doesn’t stay there for long.
“In the end, the testing didn’t reveal anything out of the ordinary,” the story reports.
So the point of it all was …?
Yes, the canine mouth, like the human mouth, is a breeding ground for germs. (Perhaps a more interesting story approach would have been if Andrews swabbed inside his own mouth, and compared the germs he might be carrying behind his own well-flossed grill with those of dogs.)
And, yes, dogs can pass on illnesses to us, and vice versa.
But spare us the scare tactics, news guys. Stop wasting our time by telling us the obvious, because, obviously, we already know that. And don’t bad-mouth dogs, no matter how bad their mouths are.
Posted by John Woestendiek May 15th, 2014 under Muttsblog, videos.
Tags: adage, bacteria, breaking news, brian andrews, broken news, dog, dogs, fear, germs, health, investigative, kiss, kisses, kissing, lab, laboratory, lick, licking, licks, manipulation, mouth, news, news media, reporter, reporting, saliva, scare tactics, special projects, television, tests, tv, zoonosis, zoonotic
With more than 500 canine clones now roaming the world, you wouldn’t think the fact that one has been produced for a pet owner in the UK would make such a big splash.
But it has, and a big splash is just what the cloners had in mind.
To introduce its unique service to Britain, Sooam Biotech, the South Korean laboratory that’s now the only company cloning dogs, borrowed from an earlier chapter in dog cloning’s bizarre history. It held a public contest, awarding a free cloning as the grand prize.
The winner: Rebecca Smith, 29, of London, who learned in late March that a clone of her 12-year-old dachshund Winnie had been born in a Seoul laboratory, BBC reported.
She named the dog Mini Winnie.
The competition saw dog owners submit videos of their dogs and compete for the chance to “immortalize” their pet for free. The bill for dog cloning normally runs around $100,000.
“Sooam Biotech is looking for one person with the most special and inspiring reason for cloning his/her beloved dog,” the company said in announcing the contest.
The contest was similar to one held in the U.S. when dog cloning first hit the market. It was called the “Golden Clone Giveaway,” and the winner was TrakR, a search and rescue dog whose owner said the German shepherd found the last survivor in the rubble of 9/11.
The weird and wacky story of how dog cloning was achieved, how it was marketed, and the first customers to sign up for it can be found in my book, “DOG, INC.: The Uncanny Inside Story of Cloning Man’s Best Friend.”
The UK’s first canine clone — who won’t arrive in the country until after a 6-month quarantine period — was cloned at Sooam Biotech, a laboratory run by Hwang Woo Suk, who was a member of the Seoul National University team that produced the world’s first canine clone, Snuppy, in 2005.
That research began after an earlier effort to clone a dog in the U.S., at Texas A&M University, was unsuccessful.
The Texas A&M research was funded by John Sperling, founder of the University of Phoenix. After cloning a cat, and assorted farm animals, the Texas A&M efforts to clone a dog were called off, but Sperling’s front man, who had established a company to store the cells of dead and dying dogs (Genetic Savings & Clone), even before dog cloning was achieved, later teamed up Hwang and Sooam to offer an online auction, with the highest bidders receiving clones of their dogs.
Hwang founded his lab after getting fired from Seoul National University when his claim to have produced the world’s first cloned human embryos was deemed fraudulent. He was later convicted of embezzling research funds and illegally buying human eggs, but his 18-month sentence was suspended.
Hwang has more recently has embarked on trying to clone a woolly mammoth from 10,00-year-old remains found frozen in Siberia.
Meanwhile, he’s churning out laboratory-created dogs, more than 500 of which have been born to surrogate mother dogs at his lab and kennel.
To create Mini Winnie, a piece of skin was taken from Winnie and transported to Seoul. Cells from the sample were placed inside an anonymous donor dog’s egg cell and, with a jolt of electricity, they merged.
Then the embryo was implanted inside a surrogate dog that gave birth, via Caesarean, to Winnie on March 30.
“The world would be a better place with more Winnies in it,” Smith, 29, says in a Channel 4 documentary, “The £60,000 Puppy: Cloning Man’s Best Friend.”
Smith received the original Winnie as a present on her 18th birthday, and she says the dog helped her overcome “lots of demons,” including an eating disorder. Smith says Mini Winnie looks identical to the original, who is old and arthritic, but still alive.
Hundreds of pet owners have had dogs cloned since the first customer, a California woman who received five copies of her dead pit bull, Booger.
Critics of the process say cloning doesn’t result in the resurrection of an animal, but a laboratory-made twin, whose creation requires the involvement of numerous other dogs, and who might not act like the original at all.
Initially, two South Korean companies were cloning dogs for pet owners (and even more for research purposes), but one of the, RNL Bio, has pulled out of the dog-cloning business.
While the cloning process has grown more efficient, some animal welfare groups say risks are still high.
Dr Katy Taylor, Head of Science at The British Union for the Abolition of Vivisection, said: “Cloning is a very unpredictable and extremely wasteful process … In order to produce just one ‘perfect’ clone, many puppies with the same genes as a loved animal will be born … Some of these puppies will be aborted or will die soon after birth from unpredictable health complications and severe birth defects.”
Defective pups, and the South Korean laboratory’s failure to follow animal welfare protocols, were among the reasons cited by the American company that teamed up with Hwang for pulling out of its dog cloning arrangement.
The documentary, while it mostly follows the judges as they visit with contestants and their dogs, does go some interesting places, including Edinburg, for an interview with Sir Ian Wilmut, cloner of Dolly the sheep. Wilmut doesn’t endorse pet cloning, and says he remains skeptical of it, saying it will lead to lots of disappointed customers who, despite their hopes, won’t get an animal with the same personality as the original.
There’s also an interview with a pet owner, not a contestant, who views dog cloning as a Hitleresque pursuit, and there are several allusions to the fact that some Koreans eat dog meat.
“The £60,000 Puppy: Cloning Man’s Best Friend” was made by the same independent production company that produced “I Cloned My Pet,” several episodes of which appeared on TLC.
“The £60,000 Puppy” is an improvement over those productions, which brushed aside most ethical questions and animal welfare concerns about pet cloning. While the new documentary doesn’t delve too deeply into them either, it does present something more than a one-sided view.
Like the earlier documentaries, it reinforces that most customers of dog cloning are, shall we say, eccentric sorts, and that their attachment to their dogs — as with all of us — is a powerful one.
Perhaps the most telling moment, though, comes as the judges debate — American Idol style — the public relations benefits of each contestant.
After that, the winner is … after a long, long pause … announced.
Cloning, it seems, is no longer some futuristic pipedream. It has become a reality, and apparently an entertainment form.
My view? Cloning is no game show, or at least it shouldn’t be.
(Photos: Top, Mini Winnie / Channel 4; middle, Hwang in his lab / John Woestendiek; bottom; Smith and the original Winnie / Channel 4)
Posted by John Woestendiek April 11th, 2014 under Muttsblog.
Tags: animals, biotech, book, canine, cells, clone, cloned, clones, cloning, contest, customers, dog cloning, dog cloning book, dog inc., dogs, free cloning, great britain, hwang woo suk, laboratory, marketing, pets, science, seoul, seoul national university, snuppy, sooam, technology, uk